For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Trovagene, Inc.

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 76.9

EPO Patents = 13

Trademarks = 3

Forward Citations = 265

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Samuil R Umansky (10 out of 20 patents)

Hovsep S Melkonyan (10 out of 11 patents)

Angela Cannas (4 out of 4 patents)

4. Louis David Tomei (4 out of 4 patents)

5. Brunangelo Falini (2 out of 9 patents)

6. Erik Meyer (2 out of 2 patents)

7. William John Feaver (2 out of 2 patents)

8. Zhenghan M Xin (2 out of 2 patents)

9. Raul Rabadan (1 out of 8 patents)

10. Cristina Mecucci (1 out of 5 patents)

11. Eugene M Shekhtman (1 out of 1 patent)

12. Jason Poole (1 out of 1 patent)

13. Saege Handcock (1 out of 1 patent)

14. Karena Kosco (1 out of 1 patent)

15. Vlada Melnikova (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 9909118 - Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media (2018-03-06),

2. 9816148 - Amplification and sequencing of transrenal nucleic acids (2017-11-14),

3. 9725767 - Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof (2017-08-08),

4. 9725755 - Synthesis and enrichment of nucleic acid sequences (2017-08-08),

5. 9453265 - Method for detection of high risk human papillomavirus (2016-09-27),

6. 9222137 - Method for monitoring minimal residual hairy cell leukemia (2015-12-29),

7. 9163229 - Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media (2015-10-20),

8. 8642261 - Genetic marker for detection of human papillomavirus (2014-02-04),

9. 8486626 - Methods of detecting cell-free miRNA in urine and blood (2013-07-16),

10. 8383335 - Method for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine (2013-02-26),

11. 7973154 - Kits for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine (2011-07-05),

12. 7914982 - Methods for detecting pathogen specific nucleic acids in urine (2011-03-29),

13. 7803929 - Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine (2010-09-28),

Company Overview

Trovagene, Inc. is a biotechnology company based in San Diego, California, specializing in the development of non-invasive molecular diagnostics. The company focuses on advancing precision medicine through its proprietary technologies that enable the detection of genetic mutations in circulating cell-free DNA. Trovagene's innovative approach aims to improve patient outcomes in oncology by providing actionable insights for personalized treatment strategies, thereby enhancing the overall management of cancer care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#411 in San Diego, CA

#5,664 in California

#23,863 in US

#45,104 in the World

San Diego, CA, United States of America

Trovagene, Inc.

Forward Citations = 265

21 inventors:

Samuil R Umansky (10 out of 20 patents)

Hovsep S Melkonyan (10 out of 11 patents)

Angela Cannas (4 out of 4 patents)

4. Louis David Tomei (4 out of 4 patents)

5. Brunangelo Falini (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trovagene, Inc.. Retrieved from https://idiyas.com/company/trovagene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…